Skip to content

Clinical trials

Hypertension, Pulmonary trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Country / region: India Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20092
20111
20121
20171
20181
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated4
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
Post Graduate Institute of Medical Education and Research, Chandigarh2
United Therapeutics2
Actelion1
Idorsia Pharmaceuticals Ltd.1
Nilratan Sircar Medical College1
Prof. Valérie Mc Lin1
Sir Takhtasinhji General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary12
Pulmonary Arterial Hypertension4
Congenital Portosystemic Shunt1
Heart Diseases1
Heart Failure1
Heart Septal Defects1
Heart Septal Defects, Atrial1
Heart Septal Defects, Ventricular1
Hepatic Encephalopathy1
Hepatopulmonary Syndrome1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.